Chimeric antigen receptor (CAR) T-cell therapy has emerged as an option for relapsed/refractory
aggressive B-cell lymphomas that have failed 2 lines of therapy. Failures usually occur …

The prognostic value of interim positron emission tomography (PET) interpreted according
to visual criteria is a matter of debate in diffuse large B-cell lymphoma (DLBCL). Maximal …

Purpose The role of interim PET/CT in guiding therapeutic strategies in diffuse large B-cell
lymphoma (DLBCL) is debated, mainly because interpretation rules vary among centres. This …

Purpose We investigated the prognostic value of total metabolic tumour volume (TMTV) in
diffuse large B-cell lymphoma (DLBCL). Methods TMTV was measured in 114 patients with …

Purpose [ 18 F]Fluorodeoxyglucose positron emission tomography (PET) is widely used for
the staging and restaging of patients with aggressive lymphoma, but less is known about the …

In newly diagnosed diffuse large B-cell lymphoma (DLBCL), the sensitivity of bone marrow
biopsy (BMB) for the detection of bone marrow involvement (BMI) can be low because of …

Purpose To evaluate, in breast cancer patients treated by neoadjuvant chemotherapy, the
predictive value of reduction in FDG uptake with regard to complete pathological response (…

Background Increased-dose bleomycin, etoposide, doxorubicin, cyclophosphamide,
vincristine, procarbazine, and prednisone (BEACOPP escalated ) improves progression-free …

Purpose The presence of a bulky tumour at staging in Hodgkin lymphoma (HL) is a predictor
of a poor outcome. The total metabolic tumour volume at baseline (TMTV0) computed on …

Background The value of 18 F-fluorodeoxyglucose (FDG) PET-CT (PET) imaging in response
assessment after first-line rituximab chemotherapy for follicular lymphoma has been …